Dishman Pharma to invest Rs 35 cr in drug unit

Dishman Pharmaceuticals & Chemicals is setting up a Rs 35 crore drug formulations unit at Bavla in Gujarat. This decision was taken by the board of directors in a meeting today, according to a company statement.

The purpose of this formulation facility is to become a full service provider as a contract research and manufacturing (CRAM) company. Many European and US customers have expressed their interest in Dishman providing this service under contract manufacturing, the statement said. The company has no plans to enter the generic formulations market, it added.

Dishman is finalising a deal with a client for orders which will account for 30 per cent of the unit's capacity, the statement said.